Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis

Annals of the Rheumatic Diseases

Volumn 74, Issue 8, 2015, Pages 1571-1579

  Bomer, Nils ^a,b   Den Hollander, Wouter ^a   Ramos, Yolande F M ^a   Bos, Steffan D ^a,c   Van Der Breggen, Ruud ^a   Lakenberg, Nico ^a   Pepers, Barry A ^a   Van Eeden, Annelies E ^a   Darvishan, Arash ^f   Tobi, Elmar W ^a,b   Duijnisveld, Bouke J ^a   Van Den Akker, Erik B ^a,d   Heijmans, Bastiaan T ^a,c   Van Roon Mom, Willeke M C ^a   Verbeek, Fons J ^f   Van Osch, Gerjo J V M ^e   Nelissen, Rob G H H ^a   Slagboom, P Eline ^a,b,c   Meulenbelt, Ingrid ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IDEAL   (Netherlands)

^c Netherland Genomics Initiative Centre for Medical Systems Biology   (Netherlands)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 2; ALPL PROTEIN; COL1A1 PROTEIN; COLLAGENASE 3; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN; THYROID HORMONE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II;

ALLELE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CHONDROGENESIS; CONTROLLED STUDY; CPG ISLAND; DINUCLEOTIDE REPEAT; DIO2 GENE; DNA METHYLATION; ENZYME INDUCTION; EPIGENETICS; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOSITY LOSS; HIP OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARTILAGE, ARTICULAR; CHONDROGENESIS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IODIDE PEROXIDASE; LOSS OF HETEROZYGOSITY; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; THYROID HORMONES; UP-REGULATION;

EID: 84926336317     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204739     Document Type: Article

References (33)

1. Woolf A, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
2. Reynard LN, Loughlin J. The genetics and functional analysis of primary osteoarthritis susceptibility. Expert Rev Mol Med 2013;15:e2.
3. Meulenbelt I, Min JL, Bos S, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet 2008;17:1867-75.
4. Meulenbelt I, Bos SD, Chapman K, et al. Meta-Analyses of genes modulating intracellular T3 bio-Availability reveal a possible role for the DIO3 gene in osteoarthritis susceptibility. Ann Rheum Dis 2011;70:164-7.
5. Ijiri K, Zerbini LF, Peng H, et al. Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum 2008;58:2075-87.
6. Husa M, Liu-Bryan R, Terkeltaub R. Shifting HIFs in osteoarthritis. Nat Med 2010;16:641-4.
7. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 2010;1192:230-7.
8. Reynard LN, Bui C, Canty-Laird EG, et al. Expression of the osteoarthritis-Associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 2011;20:3450-60.
9. Young DA, Bui C, Barter MJ. Understanding CpG methylation in the context of osteoarthritis. Epigenomics 2012;4:593-5.
10. Young DA. More evidence for a role of CpG methylation in the pathogenesis of osteoarthritis. Arthritis Rheum 2012.
11. Bos SD, Bovee JV, Duijnisveld BJ, et al. Increased type II deiodinase protein in OA-Affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 2012;71:1254-8.
12. Karlsson C, Dehne T, Lindahl A, et al. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 2010;18:581-92.
13. Nagase H, Nagasawa Y, Tachida Y, et al. Deiodinase 2 upregulation demonstrated in osteoarthritis patients cartilage causes cartilage destruction in tissue-specific transgenic rats. Osteoarthritis Cartilage 2013;21:514-23.
14. Valdes AM, Spector TD. The clinical relevance of genetic susceptibility to osteoarthritis. Best Pract Res Clin Rheumatol 2010;24:3-14.
15. Rosenbloom KR, Dreszer TR, Long JC, et al. ENCODE whole-genome data in the UCSC Genome Browser: update 2012. Nucleic Acids Res 2012;40:D912-17.
16. Holwerda S, de LW. Chromatin loops, gene positioning, and gene expression. Front Genet 2012;3:217.
17. Ehrich M, Nelson MR, Stanssens P, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005;102:15785-90.
18. Talens RP, Boomsma DI, Tobi EW, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J 2010;24:3135-44.
19. Tobi EW, Lumey LH, Talens RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing-And sex-specific. Hum Mol Genet 2009;18:4046-53.
20. Gereben B, Goncalves C, Harney JW, et al. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol Endocrinol 2000;14:1697-708.
21. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5.
22. Schwabe T, Neuert H, Clandinin T. A network of cadherin-mediated interactions polarizes growth cones to determine targeting specificity. Cell 2013;154:351-64.
23. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth 2012;9:671-5.
24. Bos SD, Slagboom PE, Meulenbelt I. New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr Opin Rheumatol 2008;20:553-9.
25. Saito T, Fukai A, Mabuchi A, et al. Transcriptional regulation of endochondral ossification by HIF-2[alpha] during skeletal growth and osteoarthritis development. Nat Med 2010;16:678-86.
26. Yang S, Kim J, Ryu JH, et al. Hypoxia-inducible factor-2[alpha] is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010;16:687-93.
27. Waarsing JH, Kloppenburg M, Slagboom PE, et al. Osteoarthritis susceptibility genes influence the association between hip morphology and osteoarthritis. Arthritis Rheum 2011;63:1349-54.
28. van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration Osteoarthritis Cartilage 2012;20:223-32.
29. Chatonnet F, Guyot R, Benoit G, et al. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc Natl Acad Sci 2013;110: E766-75.
30. Hellingman CA, Davidson EN, Koevoet W, et al. Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 2011;17:1157-67.
31. Bell J, Pai A, Pickrell J, et al. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol 2011;12:R10.
32. Zhang D, Cheng L, Badner JA, et al. Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain. Am J Hum Genet 2010;86:411-19.
33. Gibbs JR, van der Brug MP, Hernandez DG, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010;6:e1000952.